Literature DB >> 3936482

The amino acid sequence of a carbohydrate-containing immunoglobulin-light-chain-type amyloid-fibril protein.

T Tveteraas, K Sletten, P Westermark.   

Abstract

The amino acid sequence of an amyloid-fibril protein Es492 of immunoglobulin-lambda-light-chain origin (AL) was elucidated. The amyloid fibrils were obtained from the spleen of a patient who died from systemic amyloidosis. The amino acid sequence was elucidated from structural studies of peptides derived from digestion of the protein with trypsin, thermolysin, chymotrypsin and Staphylococcus aureus V8 proteinase and from cleavage of the protein with CNBr and BNPS-skatole. A heterogeneity in the length of the polypeptide was seen in the C-terminal region. The protein was by sequence homology to other lambda-chains shown to be of the V lambda II subgroup. Although an extensive homology was seen, some amino acid residues in positions 26, 31, 32, 40, 44, 93, 97, 98 and 99 have not previously been reported in these positions of V lambda II proteins. The significance of these residues in the fibril formation is unclear. The protein was found to contain carbohydrate, with glycosylation sites in two of the hypervariable regions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3936482      PMCID: PMC1152856          DOI: 10.1042/bj2320183

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  Primary structure of the Mcg lambda chain.

Authors:  J W Fett; H F Deutsch
Journal:  Biochemistry       Date:  1974-09-24       Impact factor: 3.162

2.  Methanolysis of the pyrrolidone ring of amino-terminal pyroglutamic acid in model peptides.

Authors:  I Kawasaki; H A Itano
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

3.  Measurement of molecular weights by electrophoresis on SDS-acrylamide gel.

Authors:  K Weber; J R Pringle; M Osborn
Journal:  Methods Enzymol       Date:  1972       Impact factor: 1.600

4.  [Structural rule of antibodies. Complete primary structure of a monoclonal immunoglobin L chain of the lambda type, subgroup II (Bence Jones protein VIL)].

Authors:  H Ponstingl; N Hilschmann
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1971-06

5.  The primary structure of a monoclonal human lambda-type immunoglobulin L-chain of subgroup II (Bence-Jones protein NEI).

Authors:  F A Garver; N Hilschmann
Journal:  Eur J Biochem       Date:  1972-03-15

6.  [Structural rule of antibodies. Primary structure of a monoclonal immunoglobulin-L-chain of the lambda type, subgroup IV (Bence-Jones-protein Kern). V. The complete amino acid sequence and its genetic interpretation].

Authors:  H Ponstingl; M Hess; N Hilschmann
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1971-02

7.  Amino acid sequences in amyloid proteins of kappa III immunoglobulin light-chain origin.

Authors:  K Sletten; P Westermark; P Pitkänen; N Thyresson; O K Olstad
Journal:  Scand J Immunol       Date:  1983-12       Impact factor: 3.487

8.  Attachment of carbohydrate to the variable region of myeloma immunoglobulin light chains.

Authors:  H C Sox; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1970-07       Impact factor: 11.205

9.  Primary structure of a deleted human lambda type immunoglobulin light chain containing carbohydrate: protein Sm lambda.

Authors:  F A Garver; L Chang; J Mendicino; T Isobe; E F Osserman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

10.  The characterization of soluble amyloid prepared in water.

Authors:  M Pras; M Schubert; D Zucker-Franklin; A Rimon; E C Franklin
Journal:  J Clin Invest       Date:  1968-04       Impact factor: 14.808

View more
  9 in total

1.  Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease.

Authors:  M Cogné; J L Preud'homme; M Bauwens; G Touchard; P Aucouturier
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 2.  Antibody variable region glycosylation: biochemical and clinical effects.

Authors:  A Wright; S L Morrison
Journal:  Springer Semin Immunopathol       Date:  1993

3.  Structural studies of a carbohydrate-containing immunoglobulin-lambda-light-chain amyloid-fibril protein (AL) of variable subgroup III.

Authors:  E Holm; K Sletten; G Husby
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

4.  The primary structure of the variable region of an immunoglobin IV light-chain amyloid-fibril protein (AL GIL).

Authors:  E M Fykse; K Sletten; G Husby; G G Cornwell
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

5.  Molecular analysis of the human immunoglobulin V lambda II gene family.

Authors:  M Irigoyen; A Manheimer-Lory; B Gaynor; B Diamond
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

6.  Complementary DNA sequence of human amyloidogenic immunoglobulin light-chain precursors.

Authors:  P Aucouturier; A A Khamlichi; J L Preud'homme; M Bauwens; G Touchard; M Cogné
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

7.  Complete primary sequences of two lambda immunoglobulin light chains in myelomas with nonamyloid (Randall-type) light chain deposition disease.

Authors:  C Decourt; G Touchard; J L Preud'homme; R Vidal; H Beaufils; M C Diemert; M Cogné
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

Review 8.  Localized AL amyloidosis: a suicidal neoplasm?

Authors:  Per Westermark
Journal:  Ups J Med Sci       Date:  2012-02-15       Impact factor: 2.384

9.  Fractionation of Fab glycosylated immunoglobulin G with concanavalin A chromatography unveils new structural properties of the molecule.

Authors:  Tao Huang; Xueling Chen; Huan Gu; Conghui Zhao; Xingmu Liu; Meiling Yan; Xiaodong Deng; Zaiping Zhang; Jiang Gu
Journal:  Oncotarget       Date:  2016-05-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.